Retraction Note: Buparlisib induces eukaryotic elongation factor-2 expression to cause treatment failure for lung cancer cells.

buparlisib (AN2025) - Adlai Nortye

http://www.ncbi.nlm.nih.gov/pubmed/42758217

Chenli Su; Danping Wang; Li Xu; Wei Mao; Xiao Zhang; Xiaomin Si; Xiaoqiang Dai

Sep 19, 2026